Nuvectis Pharma, Inc.

8-K Entered a material agreement; Other events Jun 30, 2026 8-K Other events Jun 29, 2026 8-K Entered a material agreement; Other events Jun 23, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Results of operations (earnings release) Feb 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Director or officer change Sep 25, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Other events May 9, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Entered a material agreement; Other events Feb 6, 2025 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Other events Aug 29, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Results of operations (earnings release) Mar 5, 2024 8-K Results of operations (earnings release) Nov 8, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Other events Sep 12, 2023 8-K Other events Aug 17, 2023 8-K Results of operations (earnings release) Aug 9, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Jul 3, 2023 8-K Director or officer change; Shareholder vote results Jun 16, 2023 8-K Results of operations (earnings release) May 15, 2023 10-Q Quarter ended 2023-03-31 May 10, 2023